Laporte Kathleen

DirectorQ32 Bio Inc. (QTTB) · full profile →Form 4 · filed Feb 27, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2025Disposed to issuer(D)13K$00
Feb 24, 2025Grant(A)13K$013K
Feb 24, 2025Grant(A)2K$02K
Feb 24, 2025Disposed to issuer(D)2K$00
Feb 24, 2025Disposed to issuer(D)5K$00
Feb 24, 2025Grant(A)5K$05K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-028268) within minutes of acceptance. Every field above traces to the original document. Verify it directly: